510(k) Report

510(k) · Cleared

Cleared

EndoFLIP

K160725510(k) TraditionalCleared May 1, 201646-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Crospon, Ltd. · FFX System, Gastrointestinal Motility (Electrical)

Cleared on May 1, 2016 as substantially equivalent to K991288 (G & J Electronics, Inc., 1999) and 2 other predicates after a 46-day review. Its family tree reaches back 3 generations to 1999. 4 later devices descend from it.

Decided
May 1, 2016
Review
46 days
Class
Class II
Product code
FFX
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K991288 (1999). 4 ancestors in all. 4 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2017: 1 descendant cleared2019: 1 descendant cleared2023: 2 descendants clearedK991288 · Distender Series II Barostat · G & J Electronics, Inc. · 1999K092850 · Endoflip · Crospon, Ltd. · 2009K120997 · Barostat Software Option · Crospon, Ltd. · 20121995200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant3 generations forward: 1 descendant K120997 · Barostat Software Option · Crospon, Ltd. · 2012K092850 · Endoflip · Crospon, Ltd. · 2009K991288 · Distender Series II Barostat · G & J Electronics, Inc. · 19990
  1. Root · 3 generations backK991288 Distender Series II BarostatG & J Electronics, Inc. · 1999
  2. 2 generations backK092850 EndoflipCrospon, Ltd. · 2009
  3. 1 generation backK120997 Barostat Software OptionCrospon, Ltd. · 2012
  4. This deviceK160725 EndoFLIPCrospon, Ltd. · 2016
  5. Descendant · cites it directly · 2 of its ownK183072 EndoFLIP SystemCrospon, Ltd. · 2019 · Recalled
  6. Descendant · 2 generations on · 1 of its ownK223705 EndoflipTM 300Covidien, LLC · 2023
  7. Descendant · 3 generations on · 0 of its ownK231861 EndoflipTM 300 SystemCovidien, LLC · 2023
  8. Descendant · cites it directly · 0 of its ownK170833 EndoFLIP® System with FLIP Topography moduleCrospon, Ltd. · 2017

Most influential descendants

Showing 4 of 4 · See all
  • K183072EndoFLIP SystemCrospon, Ltd. · 2019 · cites it directly2descendants
  • K223705EndoflipTM 300Covidien, LLC · 2023 · 2 generations on1descendant
  • K231861EndoflipTM 300 SystemCovidien, LLC · 2023 · 3 generations on0descendants
  • K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd. · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K991288Distender Series II BarostatG & J Electronics, Inc.1999—
−2K092850EndoflipCrospon, Ltd.2009—
−1K120997Barostat Software OptionCrospon, Ltd.2012—
0 (this device)K160725EndoFLIPCrospon, Ltd.2016—
+1K183072EndoFLIP SystemCrospon, Ltd.20191
+2K223705EndoflipTM 300Covidien, LLC2023—
+3K231861EndoflipTM 300 SystemCovidien, LLC2023—
+1K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
201910
202320
FIG. 1 — Lineage of K160725, 1999–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FFX device

  1. #1 K262621 Rapid Barostat Bag (RBB) Pump and Catheter…score 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991288Distender Series II Barostat
Summary page 4
…tility monitoring system Classification Name: FFX Device: EndoFLIP® System Predicate Device: K991288 – G&J Electronics, Distender Series II Barostat Reference Devices: K120997 – EndoFLIP® system – Crospon Ltd.…
G & J Electronics, Inc.1999—
*K120997Barostat Software Option
Summary page 4
…EndoFLIP® System Predicate Device: K991288 – G&J Electronics, Distender Series II Barostat Reference Devices: K120997 – EndoFLIP® system – Crospon Ltd. K092850 – EndoFLIP® system – Crospon Ltd. Device Descript…
Crospon, Ltd.2012—
*K092850Endoflip
Summary page 4
…91288 – G&J Electronics, Distender Series II Barostat Reference Devices: K120997 – EndoFLIP® system – Crospon Ltd. K092850 – EndoFLIP® system – Crospon Ltd. Device Description: The EndoFLIP® system and its accessory catheters are identical to the refe…
Crospon, Ltd.2009—

Also cleared against K991288: 3 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K183072EndoFLIP SystemCrospon, Ltd.20192
K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 2 companies; a new generation was cleared every 3.7 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K183072 (Crospon, Ltd., 2019) has gone furthest, with 2 descendants of its own.
  • 3 other devices also cite its predicate K991288.

How does its category compare?

All FFX devices

FFX System, Gastrointestinal Motility (Electrical): FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · FFX

1in 2025

2007: 22008: 12009: 22010: 22012: 42013: 12016: 32017: 22018: 12019: 42020: 12023: 32024: 12025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FFX

123in 2023

2012: 120 days median2016: 145 days median2019: 240 days median2023: 123 days median
2007high 240 (2019) · low 120 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FFX

2so far in 2026, the most since 2007

2009: 12011: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FFX

32in 2025

2009: 22010: 62011: 62012: 42013: 42014: 42015: 102016: 152017: 102018: 172019: 272020: 202021: 262022: 312023: 512024: 592025: 32
2007high 59 (2024) · low 0 (2007)2025

MAUDE reports naming product code FFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20092—12
20102—06
20110—16
2012412004
20131—04
20140—04
20150—010
20163145015
20172—010
20181—017
20194240027
20201—020
20210—026
20220—031
20233123051
20241—059
20251—032
20261—2—

What is it indicated for?

The EndoFLIP® System is indicated for use in a clinical setting to measure pressure and dimensions in the esophagus, pylorus, and anal sphincters. It is intended to be used as an adjunct to other diagnostic methods as part of a comprehensive evaluation of patients with symptoms consistent with gastrointestinal motility disorders. The EF-325 series of catheters can make pressure and dimensional measurements in the esophagus, pylorus, and anal sphincters…

Read the full statement (153 words)

The EndoFLIP® System is indicated for use in a clinical setting to measure pressure and dimensions in the esophagus, pylorus, and anal sphincters. It is intended to be used as an adjunct to other diagnostic methods as part of a comprehensive evaluation of patients with symptoms consistent with gastrointestinal motility disorders.

The EF-325 series of catheters can make pressure and dimensional measurements in the esophagus, pylorus, and anal sphincters; whereas the BF-325 series and EF-825 catheters can make dimensional measurements in the esophagus, pylorus, and anal sphincters. The EF-620 catheter can make dimensional measurements in the esophagus.

Other indications for use include:

» To estimate the size of a stoma produced by a gastric band (all EndoFLIP catheters)

* For use as an adjunct to a bougie for measuring the size of a gastric sleeve created during bariatric surgery, where it is suitable for diameter measurements for 22 to 60Fr sleeves (EF-620 catheter)

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K160725: EndoFLIP.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K160725

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026